Use of enoxaparin in a preterm infant

Annals of Pharmacotherapy

Volumn 34, Issue 12, 2000, Pages 1410-1413

  Dunaway, Kimberly K ^a   Gal, Peter ^b   Ransom, J Laurence ^a  

^a The Women's Hospital of Greensboro   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Enoxaparin; Neonate

Indexed keywords

ENOXAPARIN; HEPARIN; PROTEIN S;

ANTICOAGULATION; ARTICLE; BLEEDING; CASE REPORT; DOPPLER FLOWMETRY; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; HUMAN; NEWBORN; PREMATURITY; PRIORITY JOURNAL; THROMBOCYTOPENIA; THROMBOSIS;

ANTICOAGULANTS; ENOXAPARIN; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; THROMBOSIS;

EID: 0033638224     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10110     Document Type: Article

References (15)

1. Hemostatic disorders in newborns
2. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
3. Antithrombotic therapy in children
4. Development of the hemostatic system in the neonate and young infant
5. Heparin therapy in pediatric patients
6. Heparin clearance in the newborn
7. Standard assays underestimate the concentration of heparin in neonatal plasma
8. Heparin pharmacodynamics in premature infants
9. Low-molecular-weight heparins for the treatment of deep-vein thrombosis
10. Low-molecular-weight heparin in pediatric patients with thrombotic disease: A dose finding study
11. Heparin
12. Low-molecular-weight heparin for venous thrombosis in a neonate
13. Deep venous thrombosis in a preterm newborn of a mother with activated protein C resistance
14. The use of low molecular weight heparin in pediatric patients: A prospective cohort study